Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | AMGN | GILD | VRTX | BIIB |
| Company | Lexicon Pharmaceutcl | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.8400 | 301.75 | 65.43 | 406.42 | 221.52 |
| High | 1.8400 | 302.91 | 66.14 | 415.67 | 221.98 |
| Low | 1.7500 | 298.51 | 65.16 | 394.03 | 216.08 |
| Last | 1.7700 | 300.30 | 65.46 | 410.24 | 218.92 |
| Change | -0.0600 | +0.82 | -0.08 | +7.74 | -2.50 |
| % Change | -3.28% | +0.27% | -0.12% | +1.92% | -1.13% |
| Volume | 1,735,700 | 2,452,200 | 7,318,100 | 1,614,000 | 1,156,500 |
| 20-Day Average Volume | 3,320,405 | 2,824,205 | 7,605,860 | 1,102,530 | 1,377,420 |
| Previous Close | 1.8300 | 299.48 | 65.54 | 402.50 | 221.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7157 | 275.28 | 66.46 | 398.63 | 204.54 |
| 20-Day Raw Stochastic | 47.54% | 63.99% | 20.81% | 77.98% | 89.44% |
| 20-Day Relative Strength | 45.92% | 63.04% | 34.46% | 54.47% | 56.77% |
| Weighted Alpha | -42.58 | +28.12 | -20.14 | +17.96 | -27.18 |
| Today's Opinion | 24% Buy | 40% Buy | 100% Sell | 32% Buy | 56% Sell |
| Previous Opinion | 24% Buy | 24% Buy | 100% Sell | 8% Buy | 56% Sell |
| Last Month's Opinion | 40% Buy | 24% Sell | 100% Sell | 24% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.94% since 04/30/24 | +9.62% since 04/30/24 | +0.40% since 04/30/24 | +4.44% since 04/30/24 | +1.91% since 04/30/24 |
| Low | 1.5100 on 05/01/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 392.47 on 05/01/24 | 213.11 on 05/03/24 |
| High | 2.0200 on 05/03/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 415.67 on 05/07/24 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | -14.08% since 04/05/24 | +11.24% since 04/05/24 | -5.92% since 04/05/24 | +0.88% since 04/05/24 | +7.38% since 04/05/24 |
| Low | 1.4800 on 04/30/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 2.1682 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 415.67 on 05/07/24 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | -17.67% since 02/07/24 | +1.50% since 02/07/24 | -12.04% since 02/07/24 | -2.11% since 02/07/24 | -8.99% since 02/07/24 |
| Low | 1.4800 on 04/30/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 3.7300 on 02/16/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | +41.60% since 11/07/23 | +10.77% since 11/07/23 | -18.79% since 11/07/23 | +8.46% since 11/07/23 | -10.87% since 11/07/23 |
| Low | 0.9200 on 11/10/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 3.7300 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 450,614 | 160,633,888 | 81,602,352 | 104,029,752 | 32,238,088 |
| Shares Outstanding, K | 246,237 | 536,376 | 1,245,077 | 258,459 | 145,597 |
| Annual Sales | 1,200,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -177,120,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 1,130,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 | 2,290,500,000 |
| Last Quarter Net Income | -48,400,000 | -113,000,000 | -4,170,000,000 | 968,800,000 | 393,400,000 |
| 60-Month Beta | 1.38 | 0.60 | 0.22 | 0.39 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 05/02/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 16.07 | 29.84 | 14.50 |